Physician profile
Gregory Powell Moore
NPI 1881672699
$2,879.47
in general payments reported to CMS, 2019-2025
37 companies · $522 in 2025
The $522 reported for 2025 was more than what 76% of Gynecology providers received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $435 · 2020: $447 · 2021: $548 · 2022: $345 · 2023: $259 · 2024: $323 · 2025: $522.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,105.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,104.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $425.34 | 2021-2025 | Nexplanon, Jada System |
| Abbvie INC. | $400.37 | 2019-2023 | |
| Astellas Pharma US INC | $179.23 | 2019-2023 | Veozah, Myrbetriq |
| Pfizer INC. | $156.26 | 2019-2023 | |
| Therapeuticsmd, INC. | $141.68 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $134.45 | 2021-2025 | |
| American Regent | $125.00 | 2025 | Injectafer |
| Biogen, INC. | $124.73 | 2025 | Zurzuvae |
| Exeltis, USA INC. | $104.28 | 2020-2023 | Slynd |
| Merck Sharp & Dohme LLC | $102.25 | 2019-2021 | |
| Mayne Pharma Commercial LLC | $98.16 | 2021-2023 | |
| Radius Health, INC. | $98.15 | 2020-2021 | |
| Hologic Sales and Service, LLC | $91.25 | 2019-2024 | Acessa Provu System, Aptima, Novasure |
| Optumhealth Care Solutions, LLC | $90.98 | 2024-2025 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Amgen INC. | $63.51 | 2019-2020 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Pharmaceuticals INC. | $59.43 | 2020-2022 | |
| Amag Pharmaceuticals, INC. | $48.58 | 2019-2020 | |
| Sumitomo Pharma America, INC. | $43.29 | 2023 | Myfembree |
| Lupin INC. | $42.39 | 2019-2021 | |
| Vertical Pharmaceuticals, LLC | $39.58 | 2019-2020 | |
| Avion Pharmaceuticals | $39.27 | 2019-2021 | |
| Myovant Sciences INC. | $37.24 | 2021-2022 | |
| Minerva Surgical, INC | $30.51 | 2022 | |
| Evofem Biosciences, INC. | $28.03 | 2020-2021 | |
| Biohaven Pharmaceuticals, INC. | $22.28 | 2021 | |
| Duchesnay USA Incorporated | $21.06 | 2019 | |
| Abiomed | $19.86 | 2024 | Impella |
| Cumberland Pharmaceuticals, INC. | $19.69 | 2021 | |
| Meditrina | $18.96 | 2024 | |
| Innovation Technologies INC | $17.66 | 2025 | Irrisept |
| Lifenet Health | $16.62 | 2025 | Theragenesis Wound Matrix |
| Mission Pharmacal Company | $13.93 | 2019 | |
| Agile Therapeutics, INC. | $13.09 | 2021 | |
| Dysis Medical, INC. | $12.36 | 2021 |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.